{"count": 2, "results": [{"_id": "35008233", "pmid": 35008233, "pmcid": "PMC8750688", "title": "Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study", "journal": "Cancers (Basel)", "authors": ["Pusceddu S", "Vernieri C", "Di Maio M", "Prinzi N", "Torchio M", "Corti F", "Coppa J", "Buzzoni R", "Di Bartolomeo M", "Milione M", "Regnault B", "Truong Thanh XM", "Mazzaferro V", "de Braud F"], "date": "2021-12-23T00:00:00Z", "doi": "10.3390/cancers14010069", "meta_date_publication": "2021 Dec 23", "meta_volume": "14", "meta_issue": "1", "meta_pages": "", "score": 50285.3, "text_hl": "Impact of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use on @<m>DISEASE_Gastro_enteropancreatic_neuroendocrine_tumor</m> @DISEASE_MESH:C535650 @@@Enteropancreatic Neuroendocrine Tumors@@@: Post Hoc Analysis of the CLARINET Study", "citations": {"NLM": "Pusceddu S, Vernieri C, Di Maio M, Prinzi N, Torchio M, Corti F, Coppa J, Buzzoni R, Di Bartolomeo M, Milione M, Regnault B, Truong Thanh XM, Mazzaferro V, de Braud F. Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study Cancers (Basel). 2021 Dec 23;14(1):. PMID: 35008233", "BibTeX": "@article{35008233, title={Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study}, author={Pusceddu S and Vernieri C and Di Maio M and Prinzi N and Torchio M and Corti F and Coppa J and Buzzoni R and Di Bartolomeo M and Milione M and Regnault B and Truong Thanh XM and Mazzaferro V and de Braud F}, journal={Cancers (Basel)}, volume={14}, number={1}}"}}, {"_id": "39752043", "pmid": 39752043, "title": "Neuroendocrine tumors and diabetes mellitus: which treatment and which effect.", "journal": "Endocrine", "authors": ["Mazzilli R", "Zamponi V", "Mancini C", "Giorgini B", "Golisano B", "Mikovic N", "Pecora G", "Russo F", "Martiradonna M", "Paravani P", "Prosperi D", "Faggiano A"], "date": "2025-01-03T00:00:00Z", "doi": "10.1007/s12020-024-04149-9", "meta_date_publication": "2025 Jan 3", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50235.23, "text_hl": "On the other hand, the effects of anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ treatment, like @GENE_INS @GENE_3630 @@@insulin@@@, @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylureas@@@, @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@, ipeptidyl-peptidase-4 inhibitors, @GENE_GLP1R @GENE_2740 @@@Glucagon-like peptide-1 receptor@@@ agonists, and @GENE_SLC5A2 @GENE_6524 @@@Sodium-glucose cotransporter-2@@@ inhibitors on @DISEASE_Neuroendocrine_Tumors @DISEASE_MESH:D018358 @@@NET@@@ are unclear. Recently, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has been investigated in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Gastro_enteropancreatic_neuroendocrine_tumor</m> @DISEASE_MESH:C535650 @@@gastroenteropancreatic NET@@@ resulting in improved progression free survival suggesting a potential antineoplastic role. ", "citations": {"NLM": "Mazzilli R, Zamponi V, Mancini C, Giorgini B, Golisano B, Mikovic N, Pecora G, Russo F, Martiradonna M, Paravani P, Prosperi D, Faggiano A. Neuroendocrine tumors and diabetes mellitus: which treatment and which effect. Endocrine. 2025 Jan 3;():. PMID: 39752043", "BibTeX": "@article{39752043, title={Neuroendocrine tumors and diabetes mellitus: which treatment and which effect.}, author={Mazzilli R and Zamponi V and Mancini C and Giorgini B and Golisano B and Mikovic N and Pecora G and Russo F and Martiradonna M and Paravani P and Prosperi D and Faggiano A}, journal={Endocrine}}"}}]}